Trial Site Detail
Drug: |
IPI-504 |
|||
|---|---|---|---|---|
Trial: |
Study of IPI-504 in GIST patients following failure of at least imatinib and sunitinib |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Terminated |
|||
Cliniques Universitaires Saint Luc |
Principal Investigator: |
Yves Humblet, MD |
|---|---|
Contact: |
+0032 2 764 10 37 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Cliniques Universitaires Saint Luc Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.